91ÑÇÉ«´«Ã½

The 91ÑÇÉ«´«Ã½ submitted written testimony to a U.S. House subcommittee late last month in which it recommended a base budget of $49.05 billion for the National Institutes of Health, $3.25 billion for National Institute of General Medical Sciences and $430.5 million for a program supporting states with historically low levels of federal research funding.

The testimony — submitted to the House Appropriations Committee’s Subcommittee on Labor, Health and Human Services, and Education on May 27 — both explained and made the case for curiosity-driven research.

“Solutions, treatments, therapies and cures are built on the foundational discoveries of basic scientific researchers. In addition, investment in basic scientific research drives long-term economic growth, induces a knowledge spillover effect, increases productivity and encourages more public–private collaboration,” the society wrote.

The 91ÑÇÉ«´«Ã½’s recommendation of $49.05 billion as a topline appropriation for the NIH would represent an increase of almost 8% over fiscal year 2022. In comparison, President Joe Biden’s proposed budget would increase NIH’s base budget by a mere $275 million.

“While we recognize that Congress has allocated a significant amount of emergency funding to the NIH to combat COVID-19, those supplements do not replace consistent, sustained year-over appropriations for the agency. We cannot be of a one-track mind here. We must continue to combat other serious diseases and public health threats as well,” the testimony said.

The society also explained that the NIGMS provides many training programs that help build a talented, diverse STEM workforce. The $3.25 billion that 91ÑÇÉ«´«Ã½ recommended would represent a 5% increase. In light of inflation, the agency would have almost the same spending power as it did in FY22.

Finally, the society made the case for protecting the NIH which builds research capacity in states that have historically had low levels of NIH funding.

“The program has significantly broadened the geographic distribution of NIH funds for almost three decades,” 91ÑÇÉ«´«Ã½ wrote, pointing to two particular awards that have been vital to establishing fundamental research excellence throughout the nation.

First is the award, known as COBRE. It funds outstanding investigators and research facilities in the 23 states where the aggregate success rate for NIH applications historically has been low.

The second is the program, known as INBRE, which funds research by undergraduates in the 23 states noted above. The 91ÑÇÉ«´«Ã½ pointed to the Rhode Island INBRE as a success story.

“Rhode Island investigators turned 10 years of INBRE support into 21 awards from NIH and 28 awards from NSF and other funding agencies,” the testimony said. “Notably, the Rhode Island INBRE has — and 75% of those participants are now pursuing graduate degrees in biomedical fields or working in biomedical careers.”